Chad Allen Johnson
Director · LUMOS PHARMA, INC.
Individual
- 2024
- Dec 13, 2024
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Chad Allen Johnson's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- ULSE Inc. - $146.25M in ULS purchases and sales in the last 12 months
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
- Andrew T. Kaplan - $134.38M in KLRA purchases and sales in the last 12 months
- BAIN CAPITAL INVESTORS LLC - $134.38M in KLRA purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $133.53M in APGE purchases and sales in the last 12 months
- Stephen M. Bloch - $125.05M in LQDA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Chad Allen Johnson?
Chad Allen Johnson is a corporate insider, tracked as Director of LUMOS PHARMA, INC. (LUMO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Chad Allen Johnson last file a Form 4?
The only primary Form 4 on record is dated 13 December 2024.
